Search results
Results From The WOW.Com Content Network
After extensive development studies and clinical trials by Parke-Davis the drug was approved in the European Union in 2004. The US received FDA approval for use in treating epilepsy, diabetic neuropathic pain, and postherpetic neuralgia in December 2004. Pregabalin then appeared on the US market under the brand name Lyrica in the fall of 2005 ...
Lyrica is a medication used to treat nerve pain, seizures, and other conditions. Medicare parts C and D may cover Lyrica, but its generic version may cost less.
In July 2019, the FDA approved nine drug companies to produce generic versions of Lyrica. Capsule options and a liquid version are now available. Capsule options and a liquid version are now ...
Vyvanse (lisdexamfetamine) – a pro-drug stimulant used to treat attention deficit hyperactivity disorder and binge eating disorder; Vyvanse is converted into Dexedrine in vivo; Viibryd – an antidepressant of the serotonin modulator and stimulators class; Vivactil (protriptyline) an antidepressant also used in the treatment of nerve pain
As revenue at Pfizer continues to decline, some relief may come in the form of a new indication for Lyrica, one of the company's top-selling drugs, to treat restless legs syndrome, or RLS. Lyrica ...
4-Methylpregabalin is a drug developed by Pfizer and related to pregabalin, which similarly acts as an analgesic with effectiveness against difficult to treat "atypical" pain syndromes such as neuropathic pain.
Drug Main indication Trade name 2018 sales (million USD) 2017 sales (million USD) 1 ... Lyrica 4970 5065 Largest selling pharmaceutical products of 2015
For premium support please call: 800-290-4726 more ways to reach us